Simplex Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-78,700
| Closed | -$4.62M | – | 10305 |
|
|
2023
Q4 | $4.62M | Buy |
78,700
+36,000
| +84% | +$2.02M | ﹤0.01% | 1628 |
|
|
2023
Q3 | $1.86M | Buy |
42,700
+4,700
| +12% | +$168K | ﹤0.01% | 2142 |
|
|
2023
Q2 | $1.37M | Buy |
38,000
+700
| +2% | +$28.8K | ﹤0.01% | 2293 |
|
|
2023
Q1 | $1.39M | Sell |
37,300
-32,300
| -46% | -$1.45M | ﹤0.01% | 2277 |
|
|
2022
Q4 | $3.15M | Buy |
69,600
+26,600
| +62% | +$1.72M | ﹤0.01% | 1528 |
|
|
2022
Q3 | $3M | Buy |
43,000
+39,700
| +1,203% | +$2.94M | ﹤0.01% | 1614 |
|
|
2022
Q2 | $221K | Buy |
3,300
+1,100
| +50% | +$70K | ﹤0.01% | 4484 |
|
|
2022
Q1 | $180K | Sell |
2,200
-6,300
| -74% | -$644K | ﹤0.01% | 5309 |
|
|
2021
Q4 | $1.25M | Buy |
8,500
+8,000
| +1,600% | +$1.24M | ﹤0.01% | 2574 |
|
|
2021
Q3 | $83K | Hold |
500
| – | – | ﹤0.01% | 6892 |
|
|
2021
Q2 | $80K | Buy |
500
+390
| +355% | +$62.6K | ﹤0.01% | 7054 |
|
|
2021
Q1 | $1.88M | Buy |
110
+35
| +47% | +$6.93K | ﹤0.01% | 1666 |
|
|
2020
Q4 | $1.65M | Buy |
75
+18
| +32% | +$3.89K | ﹤0.01% | 1975 |
|
|
2020
Q3 | $946K | Sell |
57
-145
| -72% | -$19.8K | ﹤0.01% | 2284 |
|
|
2020
Q2 | $2.31M | Buy |
202
+120
| +146% | +$11.6K | ﹤0.01% | 1397 |
|
|
2020
Q1 | $630K | Sell |
82
-13
| -14% | -$1.17K | ﹤0.01% | 2360 |
|
|
2019
Q4 | $1.22M | Buy |
95
+31
| +48% | +$2.99K | ﹤0.01% | 1912 |
|
|
2019
Q3 | $498K | Sell |
64
-51
| -44% | -$4.79K | ﹤0.01% | 2633 |
|
|
2019
Q2 | $1.18M | Sell |
115
-40
| -26% | -$3.11K | ﹤0.01% | 1756 |
|
|
2019
Q1 | $1.14M | Buy |
155
+145
| +1,450% | +$9.9K | ﹤0.01% | 1880 |
|
|
2018
Q4 | $42K | Sell |
10
-491
| -98% | -$19.6K | ﹤0.01% | 4698 |
|
|
2018
Q3 | $2.36M | Buy |
+501
| New | +$27.9K | 0.01% | 1106 |
|
|
2018
Q2 | – | Sell |
-16
| Closed | -$3K | – | 8029 |
|
|
2018
Q1 | $3K | Sell |
16
-17
| -52% | -$472 | ﹤0.01% | 5088 |
|
|
2017
Q4 | $1K | Sell |
33
-397
| -92% | -$6.16K | ﹤0.01% | 5707 |
|
|
2017
Q3 | $34K | Buy |
+430
| New | +$2.49K | ﹤0.01% | 2665 |
|
|
2017
Q1 | – | Sell |
-10
| Closed | -$2K | – | 6942 |
|
|
2016
Q4 | $2K | Buy |
+10
| New | +$54 | ﹤0.01% | 5168 |
|
Other funds holding MRTX
Simplex Trading's MRTX Position: Q1 2024 in Review
Simplex Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 49,585 shares — an estimated $2.91M sold.
Simplex Trading first reported a position in MRTX in Q2 2016 and held it in 21 quarters. The position peaked at $2.91M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Simplex Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 49,585 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.91M.
- Simplex Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2016 and held it in 21 quarters.
- Simplex Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $2.91M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.